Contact us

877-469-1TRM
424-208-8866

Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer (aboundsqm)

A Phase III, Randomized, Open-Label, Cross-Over, Multi-Center, Safety and Efficacy Study to Evaluate Nab-Paclitaxel (Abraxane®) as Maintenance Treatment After Induction With Nab-Paclitaxel (Abraxane®) Plus Carboplatin in Subjects With Squamous Cell Non-Small Cell Lung Cancer (NSCLC)

For more information, please visit ClinicalTrials.gov

Patient Population Investigational Product(s) Phase Status
Squamous Cell Carcinoma, Non-Small-Cell Lung nab-Paclitaxel III Open and Accruing